Bayer AG (BAYN) Given a €105.00 Price Target at Barclays PLC

Barclays PLC set a €105.00 ($122.09) price target on Bayer AG (FRA:BAYN) in a report issued on Friday. The firm currently has a sell rating on the healthcare company’s stock.

Other research analysts have also issued research reports about the stock. UBS AG set a €125.00 ($145.35) price target on shares of Bayer AG and gave the stock a buy rating in a research note on Thursday, July 27th. Sanford C. Bernstein set a €128.00 ($148.84) price target on shares of Bayer AG and gave the stock a buy rating in a research note on Thursday, July 27th. equinet AG set a €118.00 ($137.21) price target on shares of Bayer AG and gave the stock a buy rating in a research note on Thursday, July 27th. Commerzbank Ag set a €126.00 ($146.51) price target on shares of Bayer AG and gave the stock a buy rating in a research note on Thursday, July 27th. Finally, J P Morgan Chase & Co restated a buy rating on shares of Bayer AG in a research note on Monday, July 24th. One research analyst has rated the stock with a sell rating, seven have given a hold rating and fourteen have issued a buy rating to the company’s stock. The stock currently has an average rating of Buy and a consensus price target of €122.43 ($142.36).

Shares of Bayer AG (FRA BAYN) traded down €0.35 ($0.41) on Friday, hitting €107.55 ($125.06). 2,044,567 shares of the stock traded hands. Bayer AG has a 52 week low of €86.06 ($100.07) and a 52 week high of €123.82 ($143.98).

COPYRIGHT VIOLATION WARNING: This news story was originally reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this news story on another site, it was copied illegally and reposted in violation of United States and international trademark and copyright laws. The correct version of this news story can be viewed at https://sportsperspectives.com/2017/11/18/bayer-ag-bayn-given-a-105-00-price-target-at-barclays-plc.html.

Bayer AG Company Profile

Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, Crop Science, Animal Health, and Covestro segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents.

Analyst Recommendations for Bayer AG (FRA:BAYN)

Receive News & Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply